ZVRA
Zevra Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.40
−1.12%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.66x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.02x
- Net debt / EBITDA
- -1.97x
Liquidity & coverage
- Current ratio
- 5.17x
- Quick ratio
- 5.12x
- Cash ratio
- 4.56x
- Interest coverage
- 6.84x
- EBITDA / interest
- 12.79x
- Working capital
- $202.7M
Cash & dividend
- FCF / debt
- 21.81x
- Cash flow / debt
- 22.33x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026